CytoMed Therapeutics Holds Annual Shareholders Meeting
Ticker: GDTC · Form: 6-K · Filed: Jul 3, 2025 · CIK: 1873093
| Field | Detail |
|---|---|
| Company | Cytomed Therapeutics LTD (GDTC) |
| Form Type | 6-K |
| Filed Date | Jul 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting, filing-update
TL;DR
CytoMed Therapeutics held its annual shareholder meeting on June 26, 2025.
AI Summary
CytoMed Therapeutics Limited filed a Form 6-K on July 3, 2025, reporting on events for the month of July 2025. The filing indicates that the company held its Annual Shareholders Meeting on June 26, 2025, at 12:00 p.m. local time.
Why It Matters
This filing provides a routine update on corporate governance events for CytoMed Therapeutics, informing shareholders and the market about the company's operational and administrative activities.
Risk Assessment
Risk Level: low — This filing is a routine report of a corporate event (Annual Shareholders Meeting) and does not contain significant financial or operational news.
Key Players & Entities
- CytoMed Therapeutics Limited (company) — Registrant
- June 26, 2025 (date) — Date of Annual Shareholders Meeting
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed by CytoMed Therapeutics Limited pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2025.
When did CytoMed Therapeutics Limited hold its Annual Shareholders Meeting?
The Annual Shareholders Meeting was held on June 26, 2025, at 12:00 p.m. local time.
What is the principal executive office address for CytoMed Therapeutics Limited?
The principal executive office is located at 1 Commonwealth Lane #08-22, Singapore 149544.
Is CytoMed Therapeutics Limited required to file annual reports under Form 20-F or Form 40-F?
Yes, CytoMed Therapeutics Limited is indicated to file annual reports under cover of Form 20-F.
What was the former name of CytoMed Therapeutics Limited?
The former name of the company was CytoMed Therapeutics Pte. Ltd., with a date of name change on July 16, 2021.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 3, 2025 regarding CytoMed Therapeutics Ltd (GDTC).